Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2000
06/14/2000EP1007555A1 Tropoelastin derivatives
06/14/2000EP1007551A2 Vaccine against hpv
06/14/2000EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION
06/14/2000EP1007540A1 Dna molecules encoding human nuclear receptor proteins
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007537A1 Receptor protein designated 2f1
06/14/2000EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer
06/14/2000EP1007095A2 Chimeric toxins for targeted therapy
06/14/2000EP1007089A1 Anticoagulant agents useful in treatment of thrombosis
06/14/2000EP1007074A1 Hypothalamus-specific polypeptides
06/14/2000EP1007072A1 Glial cell line-derived neurotrophic factor receptors
06/14/2000EP1007069A1 Novel coding sequences
06/14/2000EP1007065A1 Preparation of collagen
06/14/2000EP1006785A1 Antimicrobial proteins
06/14/2000CN1256696A Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
06/13/2000US6075128 Materials and methods for isolating IgA immunoglobulins
06/13/2000US6075123 Cyclin-C variants, and diagnostic and therapeutic uses thereof
06/13/2000US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents
06/13/2000US6075008 Method for promoting cell proliferation and growth
06/13/2000US6074875 Materials and methods relating to the regulation of polypeptide production in cells
06/13/2000US6074873 Nucleic acids encoding NL-3
06/13/2000US6074871 Cell-culture reactor having a porous organic polymer membrane
06/13/2000US6074862 Enzymatic polypeptide that stimulates phosphorylation of kinase; for the treatment of inflammation, autoimmune diseases and cancer; anticarcinogenic agents; bactericides
06/13/2000US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein
06/13/2000US6074848 Amino acid sequence; for antiproliferative and wound healing agents
06/13/2000US6074847 Nucleotide and amino acid sequence for essential integral membrane protein with adenosine triphosphatase domain at its c-terminus; involved in degradation of a heat shock transcription factor; for screening bactericides
06/13/2000US6074846 Hepatitis C virus asialoglycoproteins
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074836 Method of marking eukaryotic cells
06/13/2000US6074828 Screening compounds by transforming cell with recombinant expression contruct which expresses excitatory amino acid transporter and analyzing cell to determine if compound binds to transporter
06/13/2000US6074817 Recombinant mono and poly antigens to detect cytomegalovirus-specific IgM in human sera by enzyme immunoassay
06/13/2000US6074646 Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000US6074639 Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins
06/13/2000CA2159079C Methods and dna expression systems for over-expression of proteins in host cells
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/09/2000CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method
06/08/2000WO2000033077A1 Cell matrix plaques of initial bone formation
06/08/2000WO2000032823A1 Dna-protein fusions and uses thereof
06/08/2000WO2000032821A1 Methods for making recombinant cells
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
06/08/2000WO2000032775A1 Pth1r and pth3r receptors
06/08/2000WO2000032773A1 Compositions and methods for increasing bone mineralization
06/08/2000WO2000032772A2 Erythropoietic compounds
06/08/2000WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032761A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000WO2000032752A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000WO2000032628A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032220A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000WO2000032215A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
06/08/2000WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor
06/08/2000WO2000015758A9 Plant resistance to insect pests mediated by viral proteins
06/08/2000WO2000015659A3 Stomach polypeptide zsig28
06/08/2000WO2000012704A9 Enhanced functional expression of g protein-coupled receptors
06/08/2000WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000009755A3 Domain specific gene evolution
06/08/2000WO2000008142A3 Fibrous proteins and the production thereof
06/08/2000WO2000004137A9 Human aspartic proteases
06/08/2000WO2000003012A3 Expression of eukaryotic peptides in plant plastids
06/08/2000DE19856463A1 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors
06/08/2000CA2566516A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2353575A1 Methods for making recombinant cells
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352749A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000CA2352538A1 Erythropoietic compounds
06/08/2000CA2352532A1 Compositions and methods for increasing bone mineralization
06/08/2000CA2352468A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006194A2 C-erbB-2 external domain: GP75
06/07/2000EP1006186A1 Human genes
06/07/2000EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs
06/07/2000EP1006178A2 An immortal cell line derived from grouper Epinephelus coioides and its applications
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005552A1 Member of the hematopoietin receptor superfamily
06/07/2000EP1005551A2 Tissue factor pathway inhibitor-3
06/07/2000EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme
06/07/2000EP1005549A2 Prostate tumor polynucleotide and antigen compositions
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005544A1 70 human secreted proteins
06/07/2000EP1005526A1 Direct expression of peptides into culture media
06/07/2000EP1005488A1 Receptor that binds trail
06/07/2000EP1005486A1 Inducible regulatory system and use thereof
1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 1125